Cascadia Capital has published its 2026 Ingredients Market Report, covering where capital is concentrating across the ingredients value chain and what’s driving valuation in today’s market.
The report draws on Cascadia’s recent transaction experience and perspective from the deal table, alongside current public market and M&A activity.
Inside the Report
- Cascadia’s perspective from the deal table. We’ve closed six transactions across the ingredients value chain in the last two years, four of them cross-border, giving us direct insight into the value drivers North American and global buyers are rewarding.
- The themes defining ingredients M&A in 2026. Strategic and financial buyers are converging on the parts of the value chain that are hardest to replicate. We explore four areas attracting particular interest: proprietary flavor and fragrance creation, clinically substantiated ingredients, global sourcing expertise, and the growing importance of CDMOs as brands increasingly outsource development.
- Public comparables and M&A activity. The report includes updated trading performance across specialty ingredient, flavor & fragrance, and primary processing peer sets, along with a review of recent strategic and sponsor transactions.
To receive a copy of the report, please reach out to George Sent or Tyler Howard. We also welcome the opportunity to connect and exchange perspectives on what we’re seeing in the market, including in person at SupplySide Global in October or PLMA in November.
